Oncolytic viruses (OVs), which selectively kill tumor cells while stimulating an anti-tumor immune response, represent a potential breakthrough in lung cancer therapy. The induction of anti-tumor ...

EGFR, or epidermal growth factor receptor, is a protein involved in driving the growth of a cancer ... If you are under the age of 50, check out the Bonnie J. Addario Lung Cancer Foundation, an ...

Whether the mutation resulting in replacement of a single amino acid (N126D) in G6PD (glucose‐6‐phosphate‐dehydrogenase) in humans confers properties that contribute to the development of vascular ...

Lung cancer is a major health concern in the Gulf Cooperation Council (GCC) countries, particularly Kuwait and Saudi ...

A peptide synthesized by researchers at the University of São Paulo (USP) in Brazil protected human lung cells against ...

The discovery focuses on prostaglandin (PG) receptors in the uterus that enhance the critical process of decidualization, which is necessary for a successful pregnancy. This finding opens the door ...

Lung cancer maintenance therapy is ongoing therapy that is administered after the acute phase of treatment has been completed. In the case of lung cancer, you would undergo first-line chemotherapy for ...

Sep. 25, 2024 — Researchers have tested a combination of treatments in mice with lung cancer and shown that these allow immunotherapies to target non-responsive ... A New Ventilator-on-a-Chip ...

This important study provides solid in-vivo evidence that CCR4 regulates the early inflammatory response during atherosclerotic plaque formation. The authors propose that altered T-cell response plays ...